Consultation opens on guide to China for Australian medtech companies
AusBiotech and an expert advisory panel have developed a draft ‘China Guide’ for Australian medtech companies and AusBiotech is now seeking comment.
The guide aims to assist small to medium-sized Australian medical technology companies (medical devices and diagnostics) that are seeking to engage with and in China. It is part of a larger project which has received funding support from the Australian Trade Commission under the Asian Business Engagement grants program.
The guide and the broader project seek to facilitate medtech trade and partnership with China by breaking down the information barriers for Australian companies about intellectual property (IP) management in China and the types of business structures that are possible for Australian companies engaging in China. The guide includes introductory information, including business and cultural details, and the regulatory context that a medtech company may consider in a strategy for China. The guide does not intend to be exhaustive or to take the place of professional advice. Instead, it is to serve as a starting point for Australian companies.
The consultation closes 27 February 2015 and the completed China Guide will be officially launched at AusMedtech 2015 (29-30 April 2015).
How to contribute to the consultation
Comments are invited from interested parties. Reviewers may wish to consider the following questions:
- Is there any section or information that is superfluous/missing?
- Is the flow/structure appropriate?
- Does any section need re-wording to increase clarity?
- Is any information now redundant, factually incorrect or superseded?
Comments should be specific and tracking changes is encouraged, so that your intention is clearly understood. The draft Word document can be accessed via the Project Manager (details below) or it may be found here.
A pre-emptive approach to treating leukaemia relapse
The monitoring of measurable residual disease (MRD), medication and low-dose chemotherapy is...
Long COVID abnormalities appear to resolve over time
Researchers at UNSW's Kirby Institute have shown that biomarkers in long COVID patients have...
RNA-targeted therapy shows promise for childhood dementia
Scientists have shown that a new RNA-targeted therapy can halt the progression of a specific type...
